96
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Same-Day versus Next-Day Dexamethasone Intracanalicular Insert Administration for Inflammation and Pain Control Following Cataract Surgery: A Retrospective Analysis

Pages 4091-4096 | Published online: 18 Oct 2021

References

  • Walters TR, Goldberg DF, Peace JH, Gow JA. Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials. Ophthalmology. 2014;121:25–33. doi:10.1016/j.ophtha.2013.07.006
  • Porela-Tiihonen S, Kokki H, Kaarniranta K, Kokki M. Recovery after cataract surgery. Acta Ophthalmol. 2016;94(Suppl 2):1–34. doi:10.1111/aos.13055
  • Porela-Tiihonen S, Kaarniranta K, Kokki M, Purhonen S, Kokki H. A prospective study on postoperative pain after cataract surgery. Clin Ophthalmol. 2013;7:1429–1435.
  • Porela-Tiihonen S, Kaarniranta K, Kokki H. Postoperative pain after cataract surgery. J Cataract Refract Surg. 2013;39:789–798. doi:10.1016/j.jcrs.2013.03.012
  • Mohammadpour M, Jafarinasab MR, Javadi MA. Outcomes of acute postoperative inflammation after cataract surgery. Eur J Ophthalmol. 2007;17:20–28. doi:10.1177/112067210701700104
  • Ianchulev T, Litoff D, Ellinger D, Stiverson K, Packer M. Office-based cataract surgery: population health outcomes study of more than 21 000 cases in the United States. Ophthalmology. 2016;123:723–728. doi:10.1016/j.ophtha.2015.12.020
  • Dua HS, Attre R. Treatment of post-operative inflammation following cataract surgery – a review. Eur Ophthalmic Rev. 2012;6:98–103. doi:10.17925/EOR.2012.06.02.98
  • American Academy of Ophthalmology. Cataract in the Adult Eye Preferred Practice Pattern. San Francisco, CA: American Academy of Ophthamology; 2016.
  • Zafar S, Wang P, Schein OD, Srikumaran D, Makary M, Woreta FA. Prescribing patterns and costs associated with postoperative eye drop use in medicare beneficiaries undergoing cataract surgery. Ophthalmology. 2020;127:573–581. doi:10.1016/j.ophtha.2019.11.005
  • Shorstein NH, Myers WG. Drop-free approaches for cataract surgery. Curr Opin Ophthalmol. 2020;31:67–73. doi:10.1097/ICU.0000000000000625
  • Lindstrom RL, Galloway MS, Grzybowski A, Liegner JT. Dropless cataract surgery: an overview. Curr Pharm Des. 2017;23:558–564. doi:10.2174/1381612822666161129150628
  • Assil KK, Greenwood MD, Gibson A, Vantipalli S, Metzinger JL, Goldstein MH. Dropless cataract surgery: modernizing perioperative medical therapy to improve outcomes and patient satisfaction. Curr Opin Ophthalmol. 2020. doi:10.1097/ICU.0000000000000708
  • Bardoloi N, Sarkar S, Pilania A, Das H. Efficacy and safety of dropless cataract surgery. Indian J Ophthalmol. 2020;68:1081–1085. doi:10.4103/ijo.IJO_1186_19
  • Walters T, Bafna S, Vold S, et al. Efficacy and safety of sustained release dexamethasone for the treatment of ocular pain and inflammation after cataract surgery: results from two phase 3 studies. J Clin Exp Ophthalmol. 2016;7:1–11. doi:10.4172/2155-9570.1000572
  • Tyson SL, Bafna S, Gira JP, et al. Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery. J Cataract Refract Surg. 2019;45:204–212. doi:10.1016/j.jcrs.2018.09.023
  • Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516.
  • Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116:S30–S36. doi:10.1016/j.ophtha.2009.06.024
  • Sleath B, Blalock S, Covert D, et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology. 2011;118:2398–2402. doi:10.1016/j.ophtha.2011.05.013
  • Holz FG, Tadayoni R, Beatty S, et al. Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration. Br J Ophthalmol. 2015;99:220–226. doi:10.1136/bjophthalmol-2014-305327
  • Singer MA, Awh CC, Sadda S, et al. HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology. 2012;119:1175–1183. doi:10.1016/j.ophtha.2011.12.016
  • Hermann MM, Ustundag C, Diestelhorst M. Electronic compliance monitoring of topical treatment after ophthalmic surgery. Int Ophthalmol. 2010;30:385–390. doi:10.1007/s10792-010-9362-3
  • An JA, Kasner O, Samek DA, Levesque V. Evaluation of eyedrop administration by inexperienced patients after cataract surgery. J Cataract Refract Surg. 2014;40:1857–1861. doi:10.1016/j.jcrs.2014.02.037
  • McCabe CM, Berdahl JP, Tyson S, et al. Patient and physician preference for an intracanalicular dexamethasone insert for treating inflammation and pain following cataract surgery. Presented via Virtual Meeting at American Society of Cataract and Refractive Surgery Annual Meeting, 2020.
  • Gira JP, Sampson R, Silverstein SM, Walters TR, Metzinger JL, Talamo JH. Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (Dextenza): results of a qualitative survey. Patient Prefer Adherence. 2017;11:487–494. doi:10.2147/PPA.S126283
  • Stephenson PDG. Real-world evaluation of postoperative in-office Dexamethasone intracanalicular insert administration for control of postoperative inflammation following cataract surgery. J Clin Ophthalmol. 2020;4:273–278.